Nifty
Sensex
:
:
11419.25
38337.01
-177.65 (-1.53%)
-560.45 (-1.44%)

Pharmaceuticals & Drugs

Rating :
62/99  (View)

BSE: 532331 | NSE: AJANTPHARM

933.30
10.35 (1.12%)
19-Jul-2019 | 3:53PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  925.00
  •  942.00
  •  903.65
  •  922.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  95992
  •  895.89
  •  1294.00
  •  873.40

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,061.03
  • 20.83
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,063.23
  • 0.97%
  • 3.59

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.52%
  • 0.45%
  • 8.40%
  • FII
  • DII
  • Others
  • 0.39%
  • 9.53%
  • 10.71%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.52
  • 6.88
  • 1.20

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.84
  • 2.31
  • -3.78

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 27.53
  • 4.54
  • -8.60

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.36
  • 28.92
  • 23.77

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.20
  • 8.93
  • 6.96

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.49
  • 19.37
  • 17.81

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Net Sales
515.16
530.31
-2.86%
485.11
587.05
-17.36%
544.11
540.38
0.69%
510.99
473.12
8.00%
Expenses
388.08
390.78
-0.69%
377.80
389.55
-3.02%
377.89
356.65
5.96%
353.50
345.66
2.27%
EBITDA
127.08
139.53
-8.92%
107.31
197.50
-45.67%
166.22
183.73
-9.53%
157.49
127.46
23.56%
EBIDTM
24.67%
26.31%
22.12%
33.64%
30.55%
34.00%
30.82%
26.94%
Other Income
1.63
5.24
-68.89%
4.41
15.15
-70.89%
15.24
9.18
66.01%
8.13
4.76
70.80%
Interest
0.77
0.11
600.00%
0.09
0.14
-35.71%
0.13
0.09
44.44%
0.17
0.07
142.86%
Depreciation
18.75
16.64
12.68%
18.67
14.98
24.63%
17.49
14.55
20.21%
17.17
13.42
27.94%
PBT
109.19
128.02
-14.71%
92.96
197.53
-52.94%
163.84
178.27
-8.09%
148.28
118.73
24.89%
Tax
20.30
33.53
-39.46%
26.06
50.06
-47.94%
38.45
46.38
-17.10%
42.49
23.94
77.49%
PAT
88.89
94.49
-5.93%
66.90
147.47
-54.63%
125.39
131.89
-4.93%
105.79
94.79
11.60%
PATM
17.25%
17.82%
13.79%
25.12%
23.05%
24.41%
20.70%
20.04%
EPS
10.14
10.68
-5.06%
7.56
16.67
-54.65%
14.18
14.91
-4.90%
11.96
10.72
11.57%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
2,055.37
2,125.76
1,983.26
1,733.98
1,473.56
1,208.34
930.84
677.39
498.83
409.14
Net Sales Growth
-
-3.31%
7.19%
14.38%
17.67%
21.95%
29.81%
37.42%
35.80%
21.92%
 
Cost Of Goods Sold
-
295.72
317.35
322.58
317.33
290.33
283.98
250.11
187.93
153.04
139.80
Gross Profit
-
1,759.65
1,808.41
1,660.68
1,416.65
1,183.23
924.36
680.73
489.46
345.80
269.35
GP Margin
-
85.61%
85.07%
83.73%
81.70%
80.30%
76.50%
73.13%
72.26%
69.32%
65.83%
Total Expenditure
-
1,488.94
1,467.37
1,296.38
1,146.92
968.33
839.59
706.35
545.36
409.13
330.58
Power & Fuel Cost
-
32.65
27.42
18.70
15.49
12.91
11.20
10.25
7.83
6.16
4.77
% Of Sales
-
1.59%
1.29%
0.94%
0.89%
0.88%
0.93%
1.10%
1.16%
1.23%
1.17%
Employee Cost
-
430.71
376.47
295.42
256.64
200.58
156.97
123.18
93.84
70.85
45.23
% Of Sales
-
20.96%
17.71%
14.90%
14.80%
13.61%
12.99%
13.23%
13.85%
14.20%
11.05%
Manufacturing Exp.
-
174.78
215.80
192.70
174.40
130.81
96.29
81.76
60.60
40.45
31.19
% Of Sales
-
8.50%
10.15%
9.72%
10.06%
8.88%
7.97%
8.78%
8.95%
8.11%
7.62%
General & Admin Exp.
-
146.07
117.90
92.02
66.24
50.99
47.40
37.02
33.88
24.80
22.78
% Of Sales
-
7.11%
5.55%
4.64%
3.82%
3.46%
3.92%
3.98%
5.00%
4.97%
5.57%
Selling & Distn. Exp.
-
320.98
306.30
270.92
245.92
233.96
201.57
169.99
131.40
90.69
78.22
% Of Sales
-
15.62%
14.41%
13.66%
14.18%
15.88%
16.68%
18.26%
19.40%
18.18%
19.12%
Miscellaneous Exp.
-
88.03
106.13
104.04
70.90
48.75
42.18
34.04
29.88
23.15
78.22
% Of Sales
-
4.28%
4.99%
5.25%
4.09%
3.31%
3.49%
3.66%
4.41%
4.64%
2.10%
EBITDA
-
566.43
658.39
686.88
587.06
505.23
368.75
224.49
132.03
89.70
78.56
EBITDA Margin
-
27.56%
30.97%
34.63%
33.86%
34.29%
30.52%
24.12%
19.49%
17.98%
19.20%
Other Income
-
21.08
24.16
23.86
21.15
16.80
13.71
5.60
6.22
9.45
1.09
Interest
-
1.16
0.41
1.36
4.89
5.92
8.73
19.13
15.43
18.02
20.15
Depreciation
-
72.08
59.59
61.21
44.43
51.64
43.88
34.17
31.87
24.75
20.73
PBT
-
514.27
622.55
648.17
558.89
464.47
329.85
176.79
90.95
56.39
38.76
Tax
-
127.30
153.91
141.34
143.28
146.15
95.97
64.68
13.69
5.67
4.76
Tax Rate
-
24.75%
24.72%
21.81%
25.64%
32.05%
29.10%
36.59%
15.05%
10.05%
12.28%
PAT
-
386.97
468.64
506.83
415.61
309.86
233.88
112.11
77.26
50.71
34.00
PAT before Minority Interest
-
386.97
468.64
506.83
415.61
309.86
233.88
112.11
77.26
50.71
34.00
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
18.83%
22.05%
25.56%
23.97%
21.03%
19.36%
12.04%
11.41%
10.17%
8.31%
PAT Growth
-
-17.43%
-7.54%
21.95%
34.13%
32.49%
108.62%
45.11%
52.36%
49.15%
 
Unadjusted EPS
-
43.97
53.26
57.59
47.23
35.24
66.53
31.91
32.98
43.31
29.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
2,245.21
2,041.37
1,567.69
1,190.86
841.09
593.31
393.43
298.03
228.83
184.92
Share Capital
17.54
17.69
17.69
17.69
17.68
17.67
11.80
11.80
11.80
11.80
Total Reserves
2,226.57
2,023.68
1,550.00
1,173.17
822.98
575.06
381.13
286.23
217.03
173.13
Non-Current Liabilities
41.52
38.56
8.90
28.63
55.67
80.62
102.46
100.59
75.64
233.23
Secured Loans
0.66
1.01
1.04
5.79
23.31
41.53
57.57
62.09
48.13
206.20
Unsecured Loans
0.00
0.00
0.00
9.08
9.94
10.77
15.76
14.00
11.42
21.77
Long Term Provisions
13.44
13.16
4.88
2.59
4.76
2.83
2.98
4.91
2.66
0.00
Current Liabilities
377.64
346.05
246.66
259.89
249.59
275.42
222.34
250.19
217.70
76.94
Trade Payables
225.18
249.63
178.18
145.57
109.06
124.54
131.71
101.32
71.19
69.25
Other Current Liabilities
94.16
63.95
46.33
56.72
58.33
47.63
19.45
43.15
29.59
0.07
Short Term Borrowings
33.34
0.00
0.00
46.25
17.90
60.55
51.26
95.27
108.71
0.00
Short Term Provisions
24.96
32.47
22.15
11.35
64.30
42.70
19.92
10.45
8.21
7.62
Total Liabilities
2,664.37
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81
522.17
495.09
Net Block
1,178.55
1,052.66
589.17
450.74
288.09
279.39
272.56
246.12
214.03
168.46
Gross Block
1,610.34
1,417.23
894.94
715.73
549.85
492.00
438.49
378.01
313.15
242.58
Accumulated Depreciation
431.79
364.57
305.77
264.99
261.76
212.61
165.93
131.89
99.12
74.12
Non Current Assets
1,483.14
1,202.36
972.65
716.11
512.94
429.30
349.21
309.13
276.58
223.92
Capital Work in Progress
261.29
61.33
254.22
198.91
170.20
93.55
12.49
2.51
17.22
46.99
Non Current Investment
12.99
7.58
0.00
0.00
40.04
8.46
8.46
8.46
8.46
8.47
Long Term Loans & Adv.
27.65
76.79
41.88
21.29
9.34
39.15
48.61
50.75
33.54
0.00
Other Non Current Assets
2.66
4.00
2.34
4.28
5.27
8.75
7.09
1.29
3.32
0.00
Current Assets
1,181.23
1,223.62
850.60
763.27
633.41
520.05
369.02
339.68
245.59
271.18
Current Investments
64.74
182.38
181.56
76.78
19.46
55.00
0.00
0.00
0.00
0.00
Inventories
435.71
350.63
211.02
204.58
159.03
155.40
147.60
167.80
113.12
119.62
Sundry Debtors
459.48
492.02
323.15
372.35
258.76
202.22
150.47
141.00
103.98
96.72
Cash & Bank
100.51
93.09
69.95
43.37
136.76
60.39
46.23
11.48
11.53
14.84
Other Current Assets
120.79
82.39
8.63
6.80
59.40
47.04
24.72
19.40
16.96
39.99
Short Term Loans & Adv.
22.74
23.11
56.29
59.39
47.43
43.66
20.72
15.92
14.41
39.99
Net Current Assets
803.59
877.57
603.94
503.38
383.82
244.63
146.68
89.49
27.89
194.24
Total Assets
2,664.37
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81
522.17
495.10

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
374.78
285.42
609.29
326.14
279.42
212.42
234.27
70.35
95.37
95.11
PBT
514.27
622.56
648.17
558.90
456.01
329.85
163.51
90.96
56.39
38.76
Adjustment
69.04
61.60
86.33
53.07
51.21
50.82
65.28
51.35
42.76
40.13
Changes in Working Capital
-90.30
-259.14
25.88
-124.34
-81.69
-74.52
38.60
-54.53
5.96
21.57
Cash after chg. in Working capital
493.01
425.02
760.38
487.63
425.53
306.15
267.39
87.78
105.11
100.46
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-118.23
-139.60
-151.09
-161.49
-146.11
-93.73
-33.12
-17.43
-9.74
-5.35
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-222.80
-260.41
-383.12
-209.07
-158.36
-187.80
-103.70
-53.07
-50.71
-42.67
Net Fixed Assets
-392.12
-327.21
-235.38
-197.00
-138.00
-120.60
-68.66
-46.30
-38.81
-41.98
Net Investments
117.64
-1.82
-104.79
-17.41
2.22
-59.98
-1.81
0.00
0.00
0.00
Others
51.68
68.62
-42.95
5.34
-22.58
-7.22
-33.23
-6.77
-11.90
-0.69
Cash from Financing Activity
-147.46
-0.20
-201.77
-117.32
-105.19
-20.13
-104.49
-12.84
-55.89
-45.67
Net Cash Inflow / Outflow
4.52
24.81
24.40
-0.25
15.87
4.49
26.08
4.44
-11.23
6.77
Opening Cash & Equivalents
90.64
65.83
41.42
41.67
38.62
34.13
8.05
3.61
14.84
8.07
Closing Cash & Equivalent
95.16
90.64
65.82
41.42
54.49
38.62
34.13
8.05
3.61
14.84

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
257.19
231.96
178.14
135.31
95.57
67.42
44.73
33.92
26.05
21.05
ROA
15.20%
22.06%
30.69%
31.66%
29.57%
28.05%
16.40%
13.20%
9.97%
7.13%
ROE
18.07%
25.97%
36.75%
40.92%
43.24%
47.47%
32.46%
29.34%
24.52%
19.89%
ROCE
23.84%
34.49%
45.74%
51.61%
56.43%
54.53%
38.62%
23.23%
17.88%
14.37%
Fixed Asset Turnover
1.36
1.84
2.49
2.76
2.85
2.61
2.29
1.98
1.81
1.90
Receivable days
81.62
69.82
63.41
65.84
56.64
52.93
56.78
65.22
72.71
87.14
Inventory Days
69.82
48.10
37.89
37.93
38.64
45.48
61.44
74.79
84.32
98.95
Payable days
63.42
57.26
50.30
41.91
46.38
59.31
61.76
59.93
67.67
65.88
Cash Conversion Cycle
88.03
60.66
51.01
61.86
48.91
39.10
56.46
80.09
89.36
120.21
Total Debt/Equity
0.02
0.00
0.00
0.07
0.09
0.22
0.32
0.67
0.83
1.23
Interest Cover
444.34
1519.41
477.60
115.29
78.03
38.78
10.24
6.89
4.13
2.92

News Update


  • Ajanta Pharma reports 6% fall in Q4 consolidated net profit
    3rd May 2019, 09:57 AM

    The company has reported a fall of 47.30% in its standalone net profit for the quarter ended March 31, 2019

    Read More
  • Ajanta Pharma - Quarterly Results
    30th Apr 2019, 17:30 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.